Can We Predict the Sites of the Recurrence of Ovarian Cancer by F-18 FDG PET/CT Depending on CA-125 Level?


TURGUT B. , ÇİFTÇİ E. , ERTÜRK S. A. , Cetin B., Aker H., HASBEK Z.

CURRENT MEDICAL IMAGING REVIEWS, vol.13, no.4, pp.431-437, 2017 (Journal Indexed in SCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 13 Issue: 4
  • Publication Date: 2017
  • Doi Number: 10.2174/1573405613666170823154759
  • Title of Journal : CURRENT MEDICAL IMAGING REVIEWS
  • Page Numbers: pp.431-437

Abstract

Objectives: The purpose of the study is predicting the sites of the recurrence with PET/CT by serum CA-125 level and detecting the cut-off value of CA-125 for metastatic ovarian cancer (OC) in comparison with Fluorine-18 FDG PET/CT.